about
The systemic capillary leak syndrome: a case series of 28 patients from a European registryInternational and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.Prevalence of vitamin D deficiency in rheumatoid arthritis and association with disease activity and cardiovascular risk factors: data from the COMEDRA study.Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis.Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study.Infectious sacroiliitis: a retrospective, multicentre study of 39 adults.Cervical radiculopathy as a manifestation of giant cell arteritis.Refractory rheumatic disorder: atypical postpregnancy osteoporosis.Insufficiency fracture. A survey of 60 cases and review of the literature.Streptococcal septic arthritis in adults. A study of 55 cases with a literature review.How to assess early rheumatoid arthritis in daily clinical practice.Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.Selecting criteria for monitoring patients with rheumatoid arthritis.Variations in the metabolome in response to disease activity of rheumatoid arthritis.Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.Does rheumatoid synovitis activity vary during the day? Evaluation with color doppler sonography.Statins in rheumatology.Polymyalgia rheumatica: diagnosis and treatment.Atheroma and systemic lupus erythematosus.Exacerbation of interstitial lung disease during etanercept therapy: Two cases.Schnitzler syndrome.GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate.Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomesVascular endothelial growth factor levels and rheumatic diseases of the elderly.Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.Treatment of inflammatory muscle disease in adults.Spondyloarthropathies: an independent cardiovascular risk factor?TNF alpha antagonist therapy and safety monitoring.Abatacept therapy and safety management.Do all lupus patients need statins?Vascular effects of nonsteroidal antiinflammatory drugs.Rheumatoid arthritis in the elderly in the era of tight control.Cardiovascular risk in rheumatoid arthritis.Overview of biologic treatments in the elderly.Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France.
P50
Q28308214-79A732A0-C5BB-4CD4-881D-834173409882Q30234696-C6B7902A-49DC-40C1-A7FB-86DE4321835EQ31137210-91822AE7-B6A0-4C10-97CF-443BFA839FA2Q33501443-88660815-B6B3-46F2-A1A8-5546DB6022DEQ33709082-D7604173-86AC-4975-93CB-DEAC67E92094Q33725505-BD0E7015-A6BD-4349-BA55-720B7A6FA63DQ34381947-114F094A-7675-4E89-95CE-4B96A1A7E479Q34478283-AA9B0CA5-BE2C-4B5C-B616-AFD5BB7E2EAEQ34725274-A0A68465-333F-47A8-AE7D-A6C35D9B5E01Q35138328-5736E729-A254-4CAB-B5DF-14C1049EF73CQ35157665-A33B2FAD-316D-48C2-BF6F-22B769E0A81DQ35853449-606BA5CE-5AE3-4387-9B32-A4653F39739FQ35978930-D6FE3202-DF7D-4C1C-B161-B7736AB3874AQ36005210-10FFB3AD-10C4-427B-9F13-E3480A84FC19Q36009254-4A67D06C-DBF1-4A79-993B-E40840CF4874Q36083495-FE9E9977-8B6C-45B8-9754-2862B70362B6Q36109439-B6C21D52-BC53-4C6E-A705-F90934D2081FQ36245700-C07AF097-6C08-416C-BE7D-A5DE2203BFA1Q36296961-1B50F3FB-8410-40C3-A1D0-387E70366C31Q36318715-FCFD5363-12F1-494E-AAEB-893192F6B3F5Q36657210-63A1714D-EFF6-4A2D-B684-5A269128F155Q36942422-750B6516-3E05-4599-8E16-D05A36EA7C4FQ36989139-DC37445D-BD23-4860-9A05-3484DABCC9C3Q37123941-ACA3977B-83CD-4267-ADEF-0A822DB5FA15Q37177583-70A2F807-8D1E-4B19-AD26-9ED976BDD8D6Q37354812-AC51AF68-98E6-48C7-A7D7-1178ACB54FC1Q37465216-A2F6528F-1884-4A7C-9783-88480D63D582Q37465556-B45A9E20-1EB9-4C99-9BFC-24D542C116E9Q37498738-FDC04503-D5BE-47A2-B686-E64974D01ED1Q37772346-1503B722-2FCD-4919-83FF-EA1FC0F60B67Q37774455-71392F6F-E65C-4D71-B010-635FBA2DC9ABQ37894193-BAF6AE60-5FA8-40B3-A9D8-FD321513AC70Q38006176-2FA181D5-C0E1-4569-92EF-5FDECEEC05B5Q38055597-14609019-2EC4-40D3-A819-850AC71F89ECQ38116672-404236D8-89BF-4854-B955-17DCAFFFD978Q38150731-688F151B-8084-4816-9650-AAA0DE2BD5F7Q38216301-D73AC712-36E3-49E2-BFD5-3769B67B6C73Q38305623-F6BEC890-42C3-4EC8-AE9C-30B56B974ADAQ38387307-EC14309A-E318-4DDB-8ACF-3C6EF4F8C474Q38883696-3AF809F0-0DCE-43D3-83AB-97E5B74C78B2
P50
description
researcher ORCID ID = 0000-0001-9349-0720
@en
wetenschapper
@nl
name
Martin Soubrier
@ast
Martin Soubrier
@en
Martin Soubrier
@es
Martin Soubrier
@nl
type
label
Martin Soubrier
@ast
Martin Soubrier
@en
Martin Soubrier
@es
Martin Soubrier
@nl
prefLabel
Martin Soubrier
@ast
Martin Soubrier
@en
Martin Soubrier
@es
Martin Soubrier
@nl
P214
P106
P1153
57196025244
P214
P31
P496
0000-0001-9349-0720
P735
P7859
viaf-193843166